Leukotriene receptors in atherosclerosis.

Abstract

Leukotriene-forming enzymes are expressed within atherosclerotic lesions and locally produced leukotrienes exert pro-inflammatory actions within the vascular wall by means of cell surface receptors of the BLT and CysLT receptor subtypes. The migration and accumulation of inflammatory cells that follow leukotriene receptor activation have been implicated in atherosclerosis initiation and progression. Leukotriene receptors are in addition expressed on endothelial and vascular smooth muscle cells, associated with intimal hyperplasia in early atherosclerosis and restenotic lesions after angioplasty. Taken together, recent evidence suggests that leukotriene receptors may be a potential target in the treatment of atherosclerosis and in the prevention of restenosis after coronary interventions.

• Authors: Magnus Bäck, Göran K Hansson
• Journal: Annals of medicine (Ann Med) Vol. 38 Issue 7 Pg. 493-502 ( 2006) ISSN: 0785-3890 [Print] England
• PMID: 17101540 (Publication Type: Journal Article, Review)

Chemical References

• Ion Channels
• Leukotrienes
• Membrane Proteins
• Receptors, Leukotriene
• Receptors, Leukotriene B4
• cysteinyl leukotriene receptor 2
• leukotriene D4 receptor

Topics

• Animals
• Atherosclerosis (immunology, metabolism)
• Chemotaxis, Leukocyte
• Endothelial Cells (physiology)
• Humans
• Ion Channels (physiology)
• Leukotrienes (metabolism)
• Membrane Proteins (metabolism)
• Mice
• Myocytes, Smooth Muscle (physiology)
• Receptors, Leukotriene (metabolism)
• Receptors, Leukotriene B4 (physiology)